T1	Participants 44 85	patients undergoing H. pylori eradication
T2	Participants 402 529	One hundred and ninety-three (193) H. pylori-positive patients were randomly assigned to one of the following 7-day treatments:
T3	Participants 530 591	Group A (N = 64): amoxicillin, clarithromycin and rabeprazole
T4	Participants 593 668	Group B (N = 64): tinidazole, clarithromycin and ranitidine bismuth citrate
T5	Participants 670 730	Group C (N = 65): tinidazole, clarithromycin and rabeprazole
T6	Participants 925 1041	All patients were asked to complete a validated questionnaire regarding presence and intensity of drug side effects.
